- Rimola A, Bory F, Teres J, et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with
gastrointestinal hemorrhage. Hepatology 1985; 5:463–467. - Soriano G, Guarner C, Thoma ́s A, et al. Norfloxacin prevents bacterial infection in cirrhotics with
gastrointestinal hemorrhage. Gastroenterol 1992; 103:1267–1272. - Pauwels A, Mostefa-Kara N, Debenes B, et al. Systemic antibiotic prophylaxis after gastrointestinal
hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996; 24:802–806. - Hsieh W, Lin H, Hwang S, et al. The effect of ciprofloxacin in the prevention of bacterial infection in
patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998; 93:962–966. - Soares-Weiser K, Brezis M, Tur-Kaspa R, et al. Antibiotic prophylaxis for cirrhotic patients with
gastrointestinal bleeding. The Cochrane Database of Systematic Reviews 2002, 2: CD002907, 1–34. - Hirota WK, Petersen K, Baron TH, et al. American Society for Gastrointestinal Endoscopy. Guidelines
for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2003; 58:475–482. - Silverio RH, Perini RF, Arruda CB. Bacterial infection in cirrhotic patients and its relationship with
alcohol. Am J Gastroenterol 2000; 95:1290–1293. - Mandell LA. Epidemiology and etiology of community-acquired pneumonia. Infect Dis Clin N Am
2004; 18:761–776. - Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal
pneumonia. Ann Intern Med 1964; 60:759–776. - Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteremia: 325 episodes diagnosed at St. Thomas’s
Hospital. Br Med J 1985; 290:505–508. - Chen M, Hsueh P, Lee L, et al. Severe community-acquired pneumonia due toAcinetobacter baumannii.
Chest 2001;120:1072–1077. - Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American
Thoracic Society consensus guidelines on the management of community-acquired pneumonia in
adults. Clin Infect Dis 2007; 44:S27–S72. - Niederman MS, Craven DE, Bonten MJ, et al. Guidelines for the management of adults with hospital-
acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med
2005; 171:388–416. - Hlady WG, Klontz KC. The epidemiology ofVibrioinfections in Florida, 1981–1993. J Infect Dis 1996;
173:1176–1183. - Chiang S, Chuang Y.Vibrio vulnificusinfection: clinical manifestions, pathogenesis, and antimicrobial
therapy. J Microbiol Immunol Infect 2003; 36:81–88. - McCashland TM, Sorrell MF, Zetterman RK. Bacterial endocarditis in patients with chronic liver
disease. Am J Gastroenterol 1994; 89:924–927. - Hsu RB, Chen RJ, Chu SH. Infective endocarditis in patients with liver cirrhosis. J Formos Med Assoc
2004; 103:355–358. - Gonzalez-Quintela A, Martinez-Rey C, Castroagudin JF, et al. Prevalence of liver disease in patients
withStreptococcus bovisbacteremia. J Infect 2001; 42:116–119. - Tripodi MF, Adinolfi LE, Ragone E, et al.Streptococcus bovisendocarditis and its association with
chronic liver disease: an underestimated risk factor. Clin Infect Dis 2004; 38:1394–1400. - Xiol X, Castellvı ́JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a
prospective study. Hepatology 1996; 23:719–723.
Infections in Cirrhosis in Critical Care 349